Your browser doesn't support javascript.
loading
Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC).
Clemons, Mark; Mazzarello, Sasha; Hilton, John; Joy, Anil; Price-Hiller, Julie; Zhu, Xiaofu; Verma, Shailendra; Kehoe, Anne; Ibrahim, Mohammed Fk; Sienkiewicz, Marta; Stober, Carol; Vandermeer, Lisa; Hutton, Brian; Mallick, Ranjeeta; Fergusson, Dean.
Afiliação
  • Clemons M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada. mclemons@toh.ca.
  • Mazzarello S; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada. mclemons@toh.ca.
  • Hilton J; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada. mclemons@toh.ca.
  • Joy A; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
  • Price-Hiller J; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada.
  • Zhu X; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
  • Verma S; Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.
  • Kehoe A; Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.
  • Ibrahim MF; Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.
  • Sienkiewicz M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada.
  • Stober C; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada.
  • Vandermeer L; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada.
  • Hutton B; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
  • Mallick R; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
  • Fergusson D; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
Support Care Cancer ; 27(4): 1345-1354, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30099602
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Ciprofloxacina / Fator Estimulador de Colônias de Granulócitos / Antibioticoprofilaxia / Neutropenia Febril Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Ciprofloxacina / Fator Estimulador de Colônias de Granulócitos / Antibioticoprofilaxia / Neutropenia Febril Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article